| Grueber, Wesley B |
Columbia University Health Sciences
United States |
Neuron-macrophage interactions in models of chemotherapy-induced peripheral neuropathy |
5R21CA274588-02 |
|
Rachel Altshuler, Ph.D. |
| Mao, Jun J |
Sloan-Kettering Inst Can Research
United States |
Dopamine Metabolism and Nonpharmacologic Insomnia Interventions Among Cancer Survivors |
5R21CA274059-02 |
|
Marge Good, R.N., M.P.H., O.C.N. |
| Kelleher, Sarah |
Duke University
United States |
Initial Testing of a Mobile App Pain Coping Intervention for Outpatient Oncology Settings |
5R21CA273832-02 |
|
Brennan Streck, Ph.D., R.N., M.P.H. |
| Chen, Grace Y. |
University Of Michigan At Ann Arbor
United States |
Targeting cancer stem-like cells and inflammation for colon cancer chemoprevention |
5R21CA273646-02 |
|
Winfred Malone, Ph.D., M.P.H. |
| Zeng, Melody Yue |
Weill Medical Coll Of Cornell Univ
United States |
Dissecting the interplay between immunoglobulin G and the gut microbiome in cancer progression and metastasis |
5R21CA270998-02 |
|
Young Kim, Ph.D. |
| Badu-Tawiah, Abraham |
Ohio State University
United States |
Multiplexed Paper-Based Blood Test for Early-Stage Colorectal Cancer Screening |
5R21CA270727-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
Claire Zhu, Ph.D. |
| Germain, Doris A |
Icahn School Of Medicine At Mount Sinai
United States |
Exploring ovarian-derived hormone STC1 as the mediator of the protective effect of breast feeding against breast cancer. |
5R21CA270702-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
Marjorie Perloff, M.D. |
| Enzinger, Andrea C |
Dana-Farber Cancer Inst
United States |
Development of A Mindfulness-Based Mobile Health Intervention for Patients Coping with Pain from Advanced Malignancies |
5R21CA270069-02 |
|
Brennan Streck, Ph.D., R.N., M.P.H. |
| Borges, Chad R |
Arizona State University-Tempe Campus
United States |
Plate reader assays to forensically assess exposure of plasma and serum to thawed conditions |
5R21CA269091-02 |
RFA-CA-21-005 (R21 Clinical Trial Not Allowed) |
Indu Kohaar, Ph.D. |
| Katona, Bryson William |
University Of Pennsylvania
United States |
Defining the phenotype and cancer penetrance of CTNNA1 loss-of-function germline variants |
5R21CA267949-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
Asad Umar, D.V.M., Ph.D. |